Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-21-018223
Date:2021-10-11
Issuer: SATSUMA PHARMACEUTICALS, INC. (STSA)
Original Submission Date:

Reporting Person:

HARSCH MUTYA
C/O SATSUMA PHARMACEUTICALS, INC.
400 OYSTER POINT BOULEVARD, SUITE 221 SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 4.41 2021-10-11 deemed execution date A 40,000 (a) 2031-10-11 common stock 40,000 $4.41 40,000 direct
Footnotes
IDfootnote
f1 the award shall vest as to 1/36 of the shares subject to the award on each monthly anniversary from october 11, 2021, subject to continued service through each applicable vesting date
WhaleWisdom Logo

Elevate your investments